LKT LABORATORIES, INC.

Company Information
Address 2233 UNIVERSITY AVE W
ST. PAUL, MN, 55114


Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: Y

Woman Owned: N



Award Charts




Award Listing

  1. BIFUNCTIONAL ORGANOSELENIUM COMPOUNDS IN CHEMOPREVENTION

    Amount: $100,000.00

    Not Available The increasing momentum of interconnected distributed systems is revolutionizing notions of interoperability. Open standards and simple, scalable approaches to distributing data and app ...

    SBIRPhase I1999Department of Health and Human Services
  2. PROINHIBITORS OF COLON CARCINOGENESIS

    Amount: $100,000.00

    N/A

    SBIRPhase I1997Department of Health and Human Services
  3. Cancer Chemoprevention by Sulfur Compounds

    Amount: $750,001.00

    Our objectives are to design and synthesize sulfur containing compounds that stimulatedetoxifying enzymes as defenses against carcinogens. We will develop these compounds into cancerchemopreventive ag ...

    SBIRPhase II1996Department of Health and Human Services
  4. Cancer Chemoprevention by Sulfur Compounds

    Amount: $81,000.00

    N/A

    SBIRPhase I1994Department of Health and Human Services
  5. BYPASS COLOSTOMY MODEL FOR CARCINOGENESIS STUDIES

    Amount: $500,000.00

    THE OBJECTIVES OF THIS RESEARCH ARE TO STUDY THE MECHANISM OF CARCINOGENESIS AND CHEMOPREVENTION OF COLORECTAL CANCER. HUMAN COLORECTAL CANCER IS A MAJOR PROBLEM IN THE UNITED STATES AND IS SECOND ONL ...

    SBIRPhase II1993Department of Health and Human Services
  6. Glutathione Generators in Cancer Chemoprevention

    Amount: $50,000.00

    The objective of this research is to design and synthesize certain compounds that will stimulate the biosynthesis of glutathione (GSH). We will also evaluate the potential of the compounds as adjuvant ...

    SBIRPhase I1993Department of Health and Human Services
  7. Anticarcinogenic Constituents from Ganoderma Lucidum

    Amount: $50,000.00

    The objective is to isolate and characterize anticarcinogenic constituents from the fungus plant Ganoderma lucidum using bioassay-directed fractionation. The approach to the discovery of potential che ...

    SBIRPhase I1993Department of Health and Human Services
  8. Stable Derivatives of Fecapentaene

    Amount: $50,000.00

    The objectives are to synthesize stable derivatives of the human fecal mutagen, fecapentaene, and study their effects as colon carcinogens. In this Phase I study, four derivatives of fecapentaene-12 w ...

    SBIRPhase I1993Department of Health and Human Services
  9. Water-Soluble Prodrugs of Taxol Against Colon Cancer

    Amount: $50,000.00

    The objective is the development of taxol prodrugs targeted for the treatment of colon cancer. Mortality due to colorectal cancer is second only to lung cancer and is estimated to cause 58,300 deaths ...

    SBIRPhase I1993Department of Health and Human Services
  10. ISOTHIOCYNATE CONJUGATES AS CANCER CHEMOPREVENTIVES

    Amount: $50,000.00

    THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP A SERIES OF WATER SOLUBLE CONJUGATES OS ISOTHIOCYANATES AS A NOVEL TYPE OF PRODRUG WITH SITE SPECIFICITY AND LESS TOXICITY AGAINST BLADDER AND COLON CANCER. ...

    SBIRPhase I1992Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government